European Regulatory Affairs Consultancy Services

A regulatory affairs consultant helps manufacturers plan, prepare, and maintain compliance for product approvals and market access. This can include regulatory strategy, classification, technical documentation review, submission readiness assessments, gap analysis, authority correspondence, audit preparation, and post-market support. In Europe, consultants often help align documentation with EU MDR or IVDR requirements and prepare teams for Notified Body review.

These services are commonly used by medical device companies, IVD manufacturers, SaMD developers, biotech firms, and diagnostic companies entering or expanding in Europe. Startups often need strategic guidance and documentation support, while established manufacturers use consultants for remediation, submission readiness, internal audits, change assessments, and ongoing RAQA capacity when internal teams are stretched.

Yes. Elexes offers support for both EU MDR and EU IVDR, including regulatory strategy, technical documentation, GSPR alignment, clinical and performance evidence support, gap assessments, remediation planning, PMS and PMPF inputs, and submission readiness reviews. The goal is to help manufacturers build complete, defensible files that are better prepared for European regulatory scrutiny.

A submission readiness assessment is a structured review of your device, documentation, quality system, and supporting evidence against the requirements of the intended regulatory pathway. It identifies missing elements, inconsistencies, and high-risk weaknesses before formal submission. The output is typically a prioritized action plan that helps your team address gaps efficiently and avoid preventable deficiency cycles.

Yes. Technical documentation support can include file structuring, content review, authoring assistance, traceability checks, GSPR mapping, risk management alignment, labeling review, and preparation of Annex II and Annex III documentation. For CE marking, the emphasis is on creating a coherent, evidence-based file that supports conformity assessment and can be reviewed efficiently by a Notified Body.

Yes. Regulatory consultancies often support remediation after deficiency letters, audit observations, or documentation setbacks. Elexes provides targeted gap analysis, response planning, documentation correction, RMF and DHF remediation, and broader quality system support. This helps manufacturers address root issues rather than only patching isolated findings, improving both immediate responses and future regulatory interactions.

Yes. Elexes provides flexible outsourcing models, including project-based support, part-time engagement, and embedded RAQA operational support. This can cover submission management, regulatory correspondence, document control, complaint and PMS governance, audit coordination, and change impact assessments. It is especially useful for companies that need senior expertise without building a full in-house regulatory department.

Delays are often caused by incomplete documentation, weak traceability, insufficient clinical evidence, or poor alignment between quality, risk, and regulatory files. Elexes helps reduce these issues through early readiness assessments, detailed gap analysis, remediation planning, and disciplined documentation support. By identifying problems before submission and aligning evidence to European expectations, teams can move forward with fewer avoidable setbacks.